Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries
View as:

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Phase: N/A Priority: Normal
NCT ID: NCT00339586 Org: User:
Start: 01/31/06 End: - Due: -

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00798785 Org: User:
Start: 10/31/06 End: 12/31/14 Due: 12/31/15

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00379717 Org: User:
Start: 11/30/06 End: 04/30/08 Due: 04/30/09

Beta Cell Function in (Pre)Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01402037 Org: User:
Start: 07/31/11 End: 07/31/16 Due: 07/31/17

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04224922 Org: User:
Start: 05/31/15 End: 05/31/17 Due: 05/31/18

Bet Cell Therapy in Diabetes Type 1

Phase: N/A Priority: Normal
NCT ID: NCT01379729 Org: User:
Start: 05/31/11 End: 05/31/18 Due: 05/31/19

Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT00727350 Org: User:
Start: 03/31/07 End: 12/31/12 Due: 12/31/13

Beta Cell Function in (Pre) Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00800085 Org: User:
Start: 10/31/06 End: 10/31/15 Due: 10/31/16

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Phase: N/A Priority: Normal
NCT ID: NCT00409461 Org: User:
Start: - End: - Due: -

Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00627146 Org: User:
Start: 06/30/00 End: 03/31/07 Due: 03/31/08

Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes

Phase: N/A Priority: Normal
NCT ID: NCT03967938 Org: User:
Start: 02/07/19 End: 12/31/25 Due: 12/31/26

An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03810872 Org: User:
Start: 06/21/17 End: 12/31/22 Due: 12/31/23

Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00623610 Org: User:
Start: 09/30/00 End: 10/31/05 Due: 10/31/06

Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives

Phase: N/A Priority: Normal
NCT ID: NCT00654121 Org: User:
Start: 02/29/00 End: 11/30/07 Due: 11/30/08